NYSE:CHE Chemed (CHE) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free CHE Stock Alerts $561.53 -11.81 (-2.06%) (As of 03:11 PM ET) Add Compare Share Share Today's Range$560.14▼$577.1750-Day Range$573.34▼$650.7052-Week Range$492.84▼$654.62Volume64,561 shsAverage Volume79,545 shsMarket Capitalization$8.49 billionP/E Ratio30.22Dividend Yield0.28%Price Target$681.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Chemed alerts: Email Address Chemed MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside20.6% Upside$681.00 Price TargetShort InterestHealthy2.96% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-0.33Upright™ Environmental ScoreNews Sentiment0.00Based on 19 Articles This WeekInsider TradingSelling Shares$10.18 M Sold Last QuarterProj. Earnings Growth9.28%From $21.99 to $24.03 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.72 out of 5 starsMedical Sector58th out of 908 stocksHome Health Care Services Industry2nd out of 8 stocks 2.5 Analyst's Opinion Consensus RatingChemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageChemed has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.96% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Chemed has recently decreased by 3.30%, indicating that investor sentiment is improving. Previous Next 3.3 Dividend Strength Dividend YieldChemed has a dividend yield of 0.26%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthChemed has been increasing its dividend for 15 years.Dividend CoverageThe dividend payout ratio of Chemed is 8.61%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemed will have a dividend payout ratio of 6.66% next year. This indicates that Chemed will be able to sustain or increase its dividend. Previous Next 4.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreChemed has received a 80.32% net impact score from Upright. Chemed seems to create the most significant positive value in categories "Taxes", "Jobs", and "Meaning & joy". The positive contribution in the "Meaning & joy" impact category is mostly driven by its "Private hospice care", "Private home care for the elderly", and "Property water damage restoration" products. See details.Environmental SustainabilityThe Environmental Impact score for Chemed is -0.33. Previous Next 1.1 News and Social Media Coverage News SentimentChemed has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.33 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 19 news articles for Chemed this week, compared to 5 articles on an average week.Search InterestOnly 5 people have searched for CHE on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $10,184,531.00 in company stock.Percentage Held by InsidersOnly 3.32% of the stock of Chemed is held by insiders.Percentage Held by Institutions95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Chemed are expected to grow by 9.28% in the coming year, from $21.99 to $24.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemed is 30.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.37.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemed is 30.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 179.52.Price to Earnings Growth RatioChemed has a PEG Ratio of 2.48. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemed has a P/B Ratio of 7.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Chemed Stock (NYSE:CHE)Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Read More CHE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHE Stock News HeadlinesApril 2, 2024 | insidertrades.comInsider Selling: Chemed Co. (NYSE:CHE) EVP Sells 2,000 Shares of StockApril 26, 2024 | finance.yahoo.comChemed Corp (CHE) Q1 2024 Earnings Call Transcript Highlights: Diverse Performance Across ...April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? April 26, 2024 | finance.yahoo.comChemed Corporation Just Missed EPS By 14%: Here's What Analysts Think Will Happen NextApril 26, 2024 | finance.yahoo.comQ1 2024 Chemed Corp Earnings CallApril 26, 2024 | americanbankingnews.comChemed (NYSE:CHE) Shares Down 7.2% Following Weak EarningsApril 25, 2024 | msn.comCHE Stock Earnings: Chemed Misses EPS, Misses Revenue for Q1 2024April 24, 2024 | markets.businessinsider.comChemed Corp. Announces Increase In Q1 Income, but misses estimatesApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? April 24, 2024 | sfgate.comChemed: Q1 Earnings SnapshotApril 24, 2024 | businesswire.comChemed Reports First-Quarter 2024 ResultsApril 23, 2024 | msn.comChemed 2024 Earnings PreviewApril 23, 2024 | markets.businessinsider.comChemed earnings: here's what Wall Street expectsApril 21, 2024 | americanbankingnews.comCareRx (OTCMKTS:CHHHF) versus Chemed (NYSE:CHE) Critical ReviewApril 17, 2024 | finance.yahoo.comVITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and AlabamaApril 17, 2024 | businesswire.comVITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and AlabamaApril 17, 2024 | americanbankingnews.comChemed (CHE) Set to Announce Quarterly Earnings on WednesdayApril 9, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)April 3, 2024 | finance.yahoo.comChemed Corporation (CHE) Rose 13% in Q4April 1, 2024 | gurufocus.comChemed Corp Executive Vice President Spencer Lee Sells Company SharesApril 1, 2024 | finance.yahoo.comChemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25March 22, 2024 | finance.yahoo.comChemed Corp VP and Chief Legal Officer Brian Judkins Sells 11,158 SharesMarch 21, 2024 | finance.yahoo.comChemed Corporation's (NYSE:CHE) Stock Is Going Strong: Have Financials A Role To Play?March 16, 2024 | finance.yahoo.comCHE Apr 2024 670.000 callMarch 16, 2024 | finance.yahoo.comCHE Apr 2024 590.000 putMarch 13, 2024 | markets.businessinsider.comChemed's Subsidiary To Purchase Hospice Assets Of Covenant Care For $85 Mln In Florida, AlabamaMarch 13, 2024 | bizjournals.comChemed's Vitas Healthcare plans $85M acquisition to expand Florida footprintSee More Headlines Receive CHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/15 Dividend2/23/2024Dividend Payable3/15/2024Last Earnings4/24/2024Today4/26/2024Next Earnings (Estimated)7/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Home health care services Sub-IndustryHealth Care Services Current SymbolNYSE:CHE CUSIP16359R10 CIK19584 Webwww.chemed.com Phone(513) 762-6690Fax513-762-6590Employees15,087Year Founded1970Price Target and Rating Average Stock Price Target$681.00 High Stock Price Target$712.00 Low Stock Price Target$650.00 Potential Upside/Downside+20.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$18.58 Trailing P/E Ratio30.40 Forward P/E Ratio25.68 P/E Growth2.48Net Income$272.51 million Net Margins12.36% Pretax Margin15.47% Return on Equity31.69% Return on Assets20.60% Debt Debt-to-Equity RatioN/A Current Ratio1.61 Quick Ratio1.57 Sales & Book Value Annual Sales$2.26 billion Price / Sales3.77 Cash Flow$22.45 per share Price / Cash Flow25.16 Book Value$73.55 per share Price / Book7.68Miscellaneous Outstanding Shares15,120,000Free Float14,615,000Market Cap$8.54 billion OptionableOptionable Beta0.42 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Kevin J. McNamara (Age 70)CEO, President & Director Comp: $5.84MMr. Michael D. Witzeman CPA (Age 53)MBA, VP, Controller, Principal Accounting Officer & CFO Comp: $1.15MMr. Spencer S. Lee (Age 68)Executive Vice President Comp: $1.65MMr. Thomas C. Hutton (Age 73)VP & Director Mr. Nicholas Michael Westfall (Age 45)Executive Vice President Comp: $2.5MMs. Lisa A. ReinhardVP, Chief Administrative Officer & SecretarySherri WarnerDirector of Investor RelationsMr. Brian C. Judkins (Age 43)VP, Secretary & Chief Legal Officer More ExecutivesKey CompetitorsAmedisysNASDAQ:AMEDOption Care HealthNASDAQ:OPCHHenry ScheinNASDAQ:HSICQiagenNYSE:QGENRepligenNASDAQ:RGENView All CompetitorsInsiders & InstitutionsMitchell & Pahl Private Wealth LLCBought 85 shares on 4/26/2024Ownership: 0.007%Bridges Investment Management Inc.Sold 1,241 shares on 4/25/2024Ownership: 0.220%New York State Teachers Retirement SystemSold 200 shares on 4/25/2024Ownership: 0.114%CENTRAL TRUST CoSold 24 shares on 4/24/2024Ownership: 0.001%Iowa State BankSold 50 shares on 4/23/2024Ownership: 0.006%View All Insider TransactionsView All Institutional Transactions CHE Stock Analysis - Frequently Asked Questions Should I buy or sell Chemed stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares. View CHE analyst ratings or view top-rated stocks. What is Chemed's stock price target for 2024? 2 Wall Street research analysts have issued twelve-month target prices for Chemed's stock. Their CHE share price targets range from $650.00 to $712.00. On average, they anticipate the company's stock price to reach $681.00 in the next year. This suggests a possible upside of 20.6% from the stock's current price. View analysts price targets for CHE or view top-rated stocks among Wall Street analysts. How have CHE shares performed in 2024? Chemed's stock was trading at $584.75 on January 1st, 2024. Since then, CHE shares have decreased by 3.4% and is now trading at $564.75. View the best growth stocks for 2024 here. When is Chemed's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 24th 2024. View our CHE earnings forecast. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) posted its quarterly earnings results on Wednesday, April, 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.09 by $0.41. The company earned $589.23 million during the quarter, compared to analyst estimates of $587.18 million. Chemed had a net margin of 12.36% and a trailing twelve-month return on equity of 31.69%. How often does Chemed pay dividends? What is the dividend yield for Chemed? Chemed announced a quarterly dividend on Friday, February 16th. Investors of record on Monday, February 26th will be given a dividend of $0.40 per share on Friday, March 15th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date of this dividend is Friday, February 23rd. Read our dividend analysis for CHE. Is Chemed a good dividend stock? Chemed (NYSE:CHE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.26%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.61%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 6.66% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CHE. What ETFs hold Chemed's stock? ETFs with the largest weight of Chemed (NYSE:CHE) stock in their portfolio include Formidable Fortress ETF (KONG), VictoryShares THB Mid Cap ESG ETF (MDCP), Inspire Faithward Mid Cap Momentum ETF (GLRY), First Trust Dorsey Wright Momentum & Low Volatility ETF (DVOL), Opus Small Cap Value Plus ETF (OSCV), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), FIS Biblically Responsible Risk Managed ETF (PRAY) and ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL). What guidance has Chemed issued on next quarter's earnings? Chemed updated its FY 2024 earnings guidance on Wednesday, April, 24th. The company provided earnings per share (EPS) guidance of 23.300-23.700 for the period, compared to the consensus earnings per share estimate of 23.520. The company issued revenue guidance of -. What is Kevin J. McNamara's approval rating as Chemed's CEO? 1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Chemed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX). Who are Chemed's major shareholders? Chemed's stock is owned by many different institutional and retail investors. Top institutional shareholders include Raymond James & Associates (0.48%), Los Angeles Capital Management LLC (0.28%), Bridges Investment Management Inc. (0.22%), New York State Teachers Retirement System (0.11%), North Point Portfolio Managers Corp OH (0.11%) and Capital Insight Partners LLC (0.07%). Insiders that own company stock include Brian C Judkins, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View institutional ownership trends. How do I buy shares of Chemed? Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CHE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.